Binding Characteristics of the Muscarinic Receptor Subtype in Rabbit Pancreas

References

• Kuijpers G. A. J., De Pont J. J.H.H.M., van Nooy I. G.P., Fleuren-Jacobs A. M. M., Bonting S. L., Rodrigues de Miranda J. F. Amiloride is a cholinergic antagonist in the rabbit pancreas. Biochim. Biophys. Acta 1984; 804: 237–244
   PubMed Web of Science ®Google Scholar
• Hammer R., Berrie C. P., Birdsall N. J. M., Burgen A. S. V., Hulme E. C. Pirenzepine distinguishes between different subclasses of muscarinic receptors. Nature 1980; 283: 90–92
   PubMed Web of Science ®Google Scholar
• Hammer R., Giachetti A. Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterization. Life Sci. 1982; 31: 2991–2998
   PubMed Web of Science ®Google Scholar
• Birdsall N. J. M., Hulme E. C. Muscarinic receptor subclasses. Trends Pharm. Sci. 5, suppl. 1983; 4: 459–463
   Web of Science ®Google Scholar
• Hammer R., Giraldo E., Schiavi G. B., Monferini E., Ladinsky H. Binding profile of a novel cardioselective muscarinic receptor antagonist, AF-DX 116, to membranes of peripheral tissues and brain in the rat. Life Sci. 1986; 38: 1653–1662
   PubMed Web of Science ®Google Scholar
• Giraldo E., Hammer R., Ladinsky H. Distribution of muscarinic receptor subtypes in rat brain as determined in binding studies with AF-DX 116 and pirenzepine. Life Sci. 1986; 40: 833–840
   Web of Science ®Google Scholar
• Korc M., Ackerman M. S., Roeske W. R. A cholinergic antagonist identifies a subclass of muscarinic receptors in isolated rat pancreatic acini. J. Pharm. Exp. Ther. 1987; 240: 118–122
   Google Scholar
• Baudiere B., Monferini E., Giraldo E., Ladinsky H., Bali J. P. Characterization of the muscarinic receptor subtype in isolated gastric fundic cells of the rabbit. Biochem. Pharm. 1987; 36: 2957–2961
   Google Scholar
• Waelbroeck M., Camus J., Winand J., Christophe J. Different antagonist binding properties of rat pancreatic and cardiac muscarinic receptors. Life Sci. 1987; 41: 2235–2240
   Google Scholar
• Burgen A. S.V. The effects of agonists on the components of the cardiac muscarinic receptor. Br. J. Pharm. 1987; 92: 327–332
   Google Scholar
• van Koppen C. J., Rodrigues de Miranda J. F., Beld A. J., Hermanussen M. W., Lammers J. J., van Ginneken C. A.M. Characterization of the muscarinic receptor in human tracheal smooth muscle. Naunyn-Schmiedeberg's Arch. Pharm. 1985; 331: 247–252
   Google Scholar
• Larose L., Dumont Y., Asselin J., Morisset J., Poirer G. G. Muscarinic receptor of rat pancreatic acini. Eur. J. Pharm. 1981; 76: 247–254
   Google Scholar
• Hootman S. R., Picado-Leonard T. M. Effect of proteolytic cleavage on functional properties of muscarinic acetylcholine receptors in rat pancreatic and parotid acinar cells. Biochem. J. 1985; 231: 617–622
   PubMedGoogle Scholar
• Larose L., Morisset J. Cholinergic stimulation of pancreatic amylase release and muscarinic receptors: effect of ionophore A23187. Life Sci. 1985; 37: 255–261
   Google Scholar
• Brown J. H., Goldstein D. Differences in muscarinic receptor reserve for inhibition of adenylate cyclase and stimulation of phosphoinositide hydrolysis in chick heart cells. Mol. Pharm. 1986; 30: 566–570
   PubMedGoogle Scholar
• Nathanson N. M. Binding of agonists and antagonists to muscarinic acetylcholine receptors on intact cultured heart cells. J. Neurochem. 1983; 41: 1545–1549
   Google Scholar
• Marsh J. D., Smith T. W. Receptors for β-adrenergic agonists in cultured chick ventricular cells. Mol. Pharm. 1984; 27: 10–18
   Google Scholar
• Amsterdam A., Jamieson J. D. Studies on dispersed pancreatic exocrine cells I. Dissociation technique and morphologic characteristics of separated cells. J. Cell Biol. 1974; 63: 1037–1056
   PubMed Web of Science ®Google Scholar
• Willems P. H.G.M., Fleuren-Jacobs A. M. M., De Pont J. J.H.H.M., Bonting S. L. Potentiating role of cyclic AMP in pancreatic enzyme secretion, demonstrated by means of forskolin. Biochim. Biophys. Acta 1984; 802: 209–214
   Google Scholar
• Willems P. H.G.M., van Nooij I. P.G., De Pont J. J.H.H.M. Stimulatory and inhibitory effects of TMB-8 on pancreatic enzyme secretion. Biochim. Biophys. Acta 1986; 888: 255–262
   Google Scholar
• Eagle H. Amino acid metabolism in mammalian cell cultures. Science 1959; 130: 432–437
   PubMed Web of Science ®Google Scholar
• Buhl T., Rodrigues de Miranda J. F., Beld A. J., Lambrecht G., Mutschler E. Binding of the S(+)- and R(-)-enantiomers of bethanechol to muscarinic receptors in jejunal smooth muscle, nasal mucosa, atrial and ventricular myocardium of the rat. Eur. J. Pharm. 1987; 140: 221–226
   Google Scholar
• Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976; 72: 248–256
   PubMed Web of Science ®Google Scholar
• Rodrigues de Miranda J. F., Scheres H. M. E., Salden H. J. M., Beld A. J., Klaassen A. B.M., Kuijpers W. Muscarinic receptors in rat nasal mucosa are predominantly of the low affinity agonist type. Eur. J. Pharm. 1985; 113: 441–447
   PubMedGoogle Scholar
• Mizushima A., Uchida S., Zhou X-M., Kagiya T., Yoshida H. Cardiac M2 receptors consist of two different types, both regulated by GTP. Eur. J. Pharm. 1987; 135: 403–409
   Google Scholar
• Mack J. E., Matthews. Influence of veratridine on 3H-QNB binding in mouse hindbrain. J.C. Biochem. Pharm. 1987; 36(7)991–994
   Google Scholar
• Dehaye J. P., Winand J., Poloczek P., Christophe J. Characterization of muscarinic cholinergic receptors on rat pancreatic acini by N-[3H]Methylscopolamine binding. J. Biol. Chem. 1984; 259: 294–300
   PubMedGoogle Scholar
• McKinney M., Richelson E. Muscarinic responses and binding in a Murine Neuroblastoma clone (N1E-15): cyclic GMP formation is mediated by a low affinity agonist-receptor conformation and cyclic-AMP reduction is mediated by a high affinity agonist receptor. Mol. Pharm. 1986; 30: 207–211
   Google Scholar
• Cioffi C. L., El-Fakahany E. E. Short term desensi-tization of muscarinic cholinergic receptors in mouse neuroblastoma cells: selective loss of agonist low affinity and pirenzepine high affinity binding sites. J. Pharm. Exp. Ther. 1986; 238: 916–923
   PubMed Web of Science ®Google Scholar
• According to the nomenclature of muscarinic receptor subtypes proposed at the fourth International Symposium on subtypes of Muscarinic receptors in Wiesbaden we used the term M₃ instead of M_{2 β}
   Google Scholar